American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$280M |
| 2 |
Kenvue
KVUE
|
+$272M |
| 3 |
Norfolk Southern
NSC
|
+$240M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$234M |
| 5 |
Amazon
AMZN
|
+$183M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marvell Technology
MRVL
|
+$251M |
| 2 |
Walt Disney
DIS
|
+$204M |
| 3 |
Advanced Micro Devices
AMD
|
+$174M |
| 4 |
MarketAxess Holdings
MKTX
|
+$168M |
| 5 |
Johnson & Johnson
JNJ
|
+$162M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.02% |
| 2 | Healthcare | 13.44% |
| 3 | Financials | 13.33% |
| 4 | Consumer Discretionary | 11.78% |
| 5 | Industrials | 9.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2676
3D Systems Corp
DDD
$603M
| $75.5K | ﹤0.01% |
15,382
+998
| +7% | +$7.16K |
|
|
LAZR
2677
DELISTED
Luminar Technologies
LAZR
| $75.5K | ﹤0.01% |
1,106
+300
| +37% | +$27.5K |
|
2678
Aldeyra Therapeutics
ALDX
$91.7M
| $74.7K | ﹤0.01% |
11,178
-9,329
| -45% | -$69.2K |
|
|
ROVR
2679
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
| $72.4K | ﹤0.01% |
11,569
-20,013
| -63% | -$119K |
|
|
OPTU
2680
Optimum Communications Inc
OPTU
$227M
| $72.1K | ﹤0.01% |
22,052
+52
| +0.2% | +$168 |
|
|
FREE
2681
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
| $69K | ﹤0.01% |
+19,160
| New | +$73.2K |
|
|
TTSH
2682
DELISTED
Tile Shop Holdings
TTSH
| $68.9K | ﹤0.01% |
12,549
+430
| +4% | +$2.49K |
|
|
NNDM
2683
Nano Dimension
NNDM
$344M
| $68.5K | ﹤0.01% |
+25,192
| New | +$73.2K |
|
2684
AXT Inc
AXTI
$5.13B
| $67.1K | ﹤0.01% |
27,958
+6,565
| +31% | +$17.3K |
|
|
CARM
2685
DELISTED
Carisma Therapeutics
CARM
| $66.8K | ﹤0.01% |
+15,781
| New | +$99.9K |
|
2686
Acacia Research
ACTG
$455M
| $66.6K | ﹤0.01% |
18,257
+1,301
| +8% | +$4.97K |
|
2687
Stoke Therapeutics
STOK
$2.13B
| $63.6K | ﹤0.01% |
+16,143
| New | +$106K |
|
2688
Rekor Systems
REKR
$94M
| $63.4K | ﹤0.01% |
+22,491
| New | +$68.6K |
|
2689
Kopin
KOPN
$933M
| $62.7K | ﹤0.01% |
+51,416
| New | +$83.3K |
|
2690
Mistras Group
MG
$556M
| $62.6K | ﹤0.01% |
+11,488
| New | +$72.1K |
|
2691
AtaiBeckley Inc
ATAI
$2.68B
| $61.5K | ﹤0.01% |
47,663
+12,756
| +37% | +$21.9K |
|
2692
Hyliion Holdings
HYLN
$695M
| $61.1K | ﹤0.01% |
51,763
+1,153
| +2% | +$1.73K |
|
2693
Apyx Medical
APYX
$126M
| $61K | ﹤0.01% |
+19,068
| New | +$88.8K |
|
2694
Fossil Group
FOSL
$311M
| $60.5K | ﹤0.01% |
29,391
+7,680
| +35% | +$17.9K |
|
|
VISN
2695
Vistance Networks Inc
VISN
$2.67B
| $60.5K | ﹤0.01% |
18,005
+117
| +0.7% | +$479 |
|
2696
Verrica Pharmaceuticals
VRCA
$87.4M
| $59.3K | ﹤0.01% |
+1,528
| New | +$77.7K |
|
2697
C4 Therapeutics
CCCC
$480M
| $59.1K | ﹤0.01% |
31,796
+7,843
| +33% | +$23.9K |
|
|
TRUE
2698
DELISTED
TrueCar
TRUE
| $57.7K | ﹤0.01% |
27,882
+225
| +0.8% | +$516 |
|
|
LL
2699
DELISTED
LL Flooring Holdings, Inc.
LL
| $57.7K | ﹤0.01% |
18,201
+5,036
| +38% | +$18.1K |
|
2700
Acumen Pharmaceuticals
ABOS
$182M
| $57.3K | ﹤0.01% |
+13,816
| New | +$85.4K |
|
Similar funds
American Century Companies's Q3 2023 Portfolio in Review
As of Q3 2023, American Century Companies held 2,931 positions worth $130B, down 2.3% from $133B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
American Century Companies's Q3 2023 filing shows 141 new, 1,882 increased, 655 reduced and 91 closed positions. Its largest new stake was Seadrill: 2,264,354 shares worth $101M. The largest sale was Marvell Technology, an estimated $251M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- American Century Companies's largest Q3 2023 buy was Seadrill: 2,264,354 shares worth $101M.
- American Century Companies added most to NVIDIA in Q3 2023, an estimated $280M increase.
- American Century Companies's biggest Q3 2023 reduction was Marvell Technology, cutting an estimated $251M.
- American Century Companies fully exited AngloGold Ashanti in Q3 2023, selling an estimated $39.7M.
- American Century Companies's ten largest holdings make up 23% of its $130B portfolio in Q3 2023.
- American Century Companies opened 141 new positions and closed 91 in Q3 2023.
- American Century Companies's portfolio value fell 2.3% quarter-over-quarter to $130B.
Based on American Century Companies's 13F filing for Q3 2023, filed 13 Nov 2023.